SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-361097
Filing Date
2021-12-17
Accepted
2021-12-17 16:09:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d267703d424b5.htm 424B5 475379
2 GRAPHIC g267703g01k00.jpg GRAPHIC 40843
3 GRAPHIC g267703g01w13.jpg GRAPHIC 127951
4 GRAPHIC g267703g69v06.jpg GRAPHIC 62620
5 GRAPHIC g267703g85g45.jpg GRAPHIC 60939
  Complete submission text file 0001193125-21-361097.txt   871142
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254661 | Film No.: 211501599
SIC: 2834 Pharmaceutical Preparations